The US Department of Health and Human Services (HHS) has initiated a large-scale testing and research effort to investigate the causes of what is being described as an autism epidemic in the nation, according to Secretary Robert F. Kennedy Jr. during a Cabinet meeting on Thursday.
Kennedy indicated that this initiative would involve hundreds of scientists globally and aims to provide answers by September regarding the causes of rising autism rates, which he claims might be as high as 1 in 31 children.
In response, President Donald Trump observed that the revelations that could arise from this research would constitute a significant news event and hinted at the possibility of artificial factors contributing to autism.
However, experts in autism research expressed skepticism regarding the sincerity and scientific validity of the HHS effort, considering Kennedy’s controversial past of linking autism to vaccinations.
Despite robust evidence from credible sources including the National Institute of Environmental Health Sciences indicating no link between vaccinations and autism, Kennedy suggested that he would explore various “exposures” that might be responsible for autism.
The rise in autism diagnosis rates in the United States has been attributed to multiple factors, including increased awareness, broader definitions of autism, improved screening techniques, and earlier detection methods, according to the US Centers for Disease Control and Prevention (CDC).
In 2000, about 1 in 150 children were diagnosed with autism spectrum disorder; that rate has escalated to approximately 1 in 36 in 2020.
Experts suggest that genetics, advanced parental age, exposure to environmental pollutants, and other factors may play a role in autism development, while vaccines have been long determined not to be a contributing factor.
Kennedy’s historical anti-vaccine stance has drawn concern over the direction in which this research may lead, particularly as he directed the CDC to study vaccines despite previous studies consistently denying a link to autism.
Dr. Peter Marks, the leading vaccine regulator at the US Food and Drug Administration (FDA), was reportedly ousted due to disagreements with Kennedy over his insistence on pursuing a narrative linking vaccines and autism.
Moreover, Kennedy’s appointment of David Geier, a known figure in the anti-vaccine movement with a controversial history, to a prominent role as a senior data analyst has raised alarms among the autism advocacy and medical communities.
Advocates for the autism community reacted critically to Kennedy’s announcement of a rapid timeframe for research, warning that the proposed investigation lacks transparency and appears to prioritize speculative conclusions over scientific rigor.
The Autism Society of America described Kennedy’s claims about causes of autism as unrealistic and misleading, emphasizing the need for scientific integrity in autism research.
Zoe Gross, director of advocacy at the Autistic Self Advocacy Network, expressed concerns that the statements made by Kennedy indicate a pre-existing bias against vaccines as potential causal factors in autism.
Kennedy’s comments about eliminating certain exposures that might be causing autism further fueled criticisms that the research might not be genuinely explorative in nature.
The agency’s announcement comes amid a backdrop of rising measles cases in the US, which researchers and public health advocates say highlight the importance of vaccinations in preventing outbreaks.
Kennedy reportedly downplayed a recent measles outbreak in Texas, which tragically resulted in the deaths of two unvaccinated children, by suggesting various complications could have contributed to their deaths rather than the measles itself.
Despite Kennedy offering support for the measles-mumps-rubella vaccine during an interview, his equating various treatment methods, some of which are not scientifically approved for measles, has drawn criticism from health professionals.
Dr. Adam Ratner, a pediatric infectious disease specialist, reiterated the importance of vaccination in preventing measles outbreaks, stating that “the thing that stops a measles outbreak is vaccination.”
Kennedy made other statements during the Cabinet meeting, claiming that the plateauing of measles cases in the US contradicts ongoing reports from states where cases are experiencing significant growth.
Additionally, Kennedy proclaimed that his research would consider various factors, including diet, environmental influences, and parenting methods, as potential contributors to rising autism rates.
HHS Director of Communications Andrew Nixon affirmed that the NIH is dedicated to investigating the etiology of autism as a national imperative, highlighting the urgency families feel for answers amid rising diagnosis rates.
However, the ambiguity surrounding the research’s design and methodology prompted criticism from leading disability organizations, who believe any effective probe into autism’s causes must align with rigorous scientific standards.
Dr. Lisa Settles, director of Tulane’s Center for Autism and Related Disorders, voiced concerns regarding the unrealistic five-month timeframe proposed for such substantial research.
Settles underscored the extensive time needed to design a proper research program, collect data, and analyze findings, expressing doubt about the bias-free nature of the anticipated research efforts.
Veteran vaccine researcher Dr. Peter Hotez pointed out that the causes of autism have been extensively studied and outlined in existing research, questioning the necessity of a new investigation given the wealth of data already available.
Hotez speculated that the conclusions reached from Kennedy’s research might have already been predetermined and aligned with his long-held beliefs despite contradicting scientific facts about the origins of autism.
Amid these developments, concerns over HHS’s ability to effectively manage a global research initiative grow, particularly in light of recent budget cuts and staff reductions at the agency.
Public health experts marked the significant restructuring, which included a 25% staff cut, questioning the practical feasibility of coordinating an expansive research project.
“It’s hard to understand how they can carry out these goals while simultaneously reducing their budget,” said Dr. Georges Benjamin, executive director of the American Public Health Association, echoing calls for Kennedy’s resignation or termination from his post.
The discussion around autism research led by Kennedy has surfaced renewed calls for transparency and integrity in public health initiatives, especially given the heightened stakes surrounding public health and the misinformation that can emerge during such critical health advocacy efforts.
House Democrats on the Energy and Commerce Committee have also initiated a probe into Geier’s involvement in the HHS autism study, complying with previous regulatory concerns about his history in medical practices.
As the investigation progresses, autism advocates continue to urge for a scientifically valid and open approach to understanding autism’s complexities, promoting a shift away from speculative narratives that can hinder constructive discussions and contribute to misinformation around vaccines.
image source from：https://www.cnn.com/2025/04/10/health/kennedy-autism-causes/index.html
